HCA Healthcare, Inc. (NYSE:HCA) Announces Quarterly Dividend of $0.56

HCA Healthcare, Inc. (NYSE:HCAGet Rating) announced a quarterly dividend on Friday, April 22nd, RTT News reports. Investors of record on Thursday, June 16th will be paid a dividend of 0.56 per share on Thursday, June 30th. This represents a $2.24 dividend on an annualized basis and a yield of 0.93%.

HCA Healthcare has a payout ratio of 10.8% meaning its dividend is sufficiently covered by earnings. Research analysts expect HCA Healthcare to earn $20.37 per share next year, which means the company should continue to be able to cover its $2.24 annual dividend with an expected future payout ratio of 11.0%.

Shares of HCA Healthcare stock opened at $242.00 on Friday. The company has a market cap of $73.09 billion, a P/E ratio of 12.68, a PEG ratio of 1.43 and a beta of 1.60. HCA Healthcare has a 52-week low of $196.22 and a 52-week high of $279.02. The company has a quick ratio of 1.21, a current ratio of 1.41 and a debt-to-equity ratio of 23.06. The firm’s 50 day moving average price is $257.03 and its 200-day moving average price is $249.04.

HCA Healthcare (NYSE:HCAGet Rating) last posted its earnings results on Thursday, January 27th. The company reported $4.42 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.55 by ($0.13). The firm had revenue of $15.06 billion during the quarter, compared to analyst estimates of $15.41 billion. HCA Healthcare had a net margin of 11.84% and a return on equity of 303.35%. The business’s revenue for the quarter was up 5.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $4.13 earnings per share. As a group, equities research analysts forecast that HCA Healthcare will post 18.78 EPS for the current fiscal year.

In other news, insider A Bruce Moore, Jr. sold 20,633 shares of the stock in a transaction on Wednesday, February 16th. The stock was sold at an average price of $244.01, for a total transaction of $5,034,658.33. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Joseph A. Sowell III sold 11,522 shares of the firm’s stock in a transaction dated Friday, March 11th. The stock was sold at an average price of $269.00, for a total value of $3,099,418.00. The disclosure for this sale can be found here. 1.50% of the stock is owned by insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Stifel Financial Corp grew its position in HCA Healthcare by 4.1% during the 4th quarter. Stifel Financial Corp now owns 23,615 shares of the company’s stock worth $6,067,000 after acquiring an additional 933 shares during the last quarter. NewEdge Advisors LLC purchased a new position in shares of HCA Healthcare in the fourth quarter worth $2,570,000. Schonfeld Strategic Advisors LLC increased its position in HCA Healthcare by 199.3% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 9,927 shares of the company’s stock valued at $2,551,000 after acquiring an additional 19,927 shares during the last quarter. Toroso Investments LLC grew its holdings in HCA Healthcare by 75.3% during the fourth quarter. Toroso Investments LLC now owns 8,609 shares of the company’s stock valued at $2,212,000 after purchasing an additional 3,698 shares during the period. Finally, 1832 Asset Management L.P. grew its holdings in HCA Healthcare by 79.6% during the fourth quarter. 1832 Asset Management L.P. now owns 3,395 shares of the company’s stock valued at $885,000 after purchasing an additional 1,505 shares during the period. Institutional investors and hedge funds own 66.36% of the company’s stock.

HCA Healthcare announced that its Board of Directors has initiated a share buyback plan on Thursday, January 27th that permits the company to repurchase $8.00 billion in shares. This repurchase authorization permits the company to buy up to 10.9% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s management believes its stock is undervalued.

Several brokerages have recently issued reports on HCA. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, April 6th. Wells Fargo & Company assumed coverage on shares of HCA Healthcare in a research report on Monday, March 28th. They set an “equal weight” rating and a $267.00 target price on the stock. Cowen lowered their price objective on HCA Healthcare from $302.00 to $265.00 and set an “outperform” rating on the stock in a report on Friday, January 28th. Truist Financial increased their target price on shares of HCA Healthcare from $290.00 to $310.00 and gave the company a “buy” rating in a report on Wednesday, January 5th. Finally, TheStreet upgraded shares of HCA Healthcare from a “c+” rating to a “b-” rating in a research report on Monday, March 21st. Eight equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $279.55.

About HCA Healthcare (Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Dividend History for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.